LaSalle Street Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-3,445
| Closed | -$261K | – | 106 |
|
|
2018
Q2 | $261K | Sell |
3,445
-1,625
| -32% | -$123K | 0.26% | 95 |
|
|
2018
Q1 | $267K | Sell |
5,070
-226
| -4% | -$11.9K | 0.21% | 98 |
|
|
2017
Q4 | $283K | Buy |
5,296
+720
| +16% | +$38.5K | 0.2% | 96 |
|
|
2017
Q3 | $273K | Buy |
+4,576
| New | +$273K | 0.2% | 95 |
|
|
2016
Q4 | – | Sell |
-4,278
| Closed | -$299K | – | 99 |
|
|
2016
Q3 | $299K | Sell |
4,278
-3,568
| -45% | -$249K | 0.28% | 68 |
|
|
2016
Q2 | $304K | Buy |
+7,846
| New | +$304K | 0.29% | 67 |
|